CHARLES TOWN, W.V., Feb. 13 /PRNewswire-FirstCall/ -- ReBuilder Medical
Technologies, Inc. (Pink Sheets: RBRM), developers of state of the art
electronic devices for diabetic peripheral neuropathy, Molluscum
Contagiosum, and MRSA, announces 2007 sales up 89% over last year, details
are available on their Annual Report on http://www.pinksheets.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
"The company's growth has continued upward despite the nation's
concerns about economic recession and the weakening dollar. We expect to
maintain that stable growth pattern in 2008 based upon several factors 1)
we manufacture and sell our own products, 2) our products are medical in
nature and are essential to our customers, representing a less expensive
while more effective alternative to traditional therapies, 3) we have a
strong overseas market for our products, where consumers are anxious to buy
U.S. products with their stronger currencies" states David Phillips, Ph.D.,
CEO of RBRM. RBRM's annual shareholder meeting is scheduled for 3pm on
February 14, 2008.
For more information visit: http://www.rebuildermedical.com,
http://www.molluscum.com.
Safe Harbor: This letter contains certain forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended, which
are intended to be covered by the safe harbors created thereby. Investors
are cautioned that all forward-looking statements involve risks and
uncertainty, including without limitation, the ability of the Company to
successfully implement its turnaround strategy, changes in costs of raw
materials, labor, and employee benefits, as well as general market
conditions, competition and pricing. Although the Company believes that the
assumptions underlying the forward-looking statements contained herein are
reasonable, any of the assumptions could be inaccurate, and therefore,
there can be no assurance that the forward-looking statements included in
this letter will prove to be accurate. In light of the significant
uncertainties inherent in the forward-looking statements included herein,
the inclusion of such information should not be regarded as representation
by the Company or any other person that the objectives and plans of the
Company will be achieved. In assessing forward-looking statements included
herein, readers are urged to carefully read those statements. When used in
the Annual Report on Form 10-K, the words "estimate," "anticipate,"
"expect," "believe," and similar expressions are intended to be
forward-looking statements.
|
